International Clinical Trial: Observation on the Efficacy of TcbHP Regimen in Neoadjuvant Therapy for HER-2 Positive Breast Cancer and Construction of a Predictive Model

Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125225) titled 'Observation on the Efficacy of TcbHP Regimen in Neoadjuvant Therapy for HER-2 Positive Breast Cancer and Construction of a Predictive Model' on May 22.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology

Condition: HER-2 Positive Breast Cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-05-25

Target Sample Size: Disease diagnosis classification:78;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showp...